StockData
HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30

MindWalk Holdings Corp.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 20-F on Jul 23, 2026
$1.32+0.01 (+0.76%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q3 FY2026
Ended Jan 31, 2026
Mar 12, 2026Before market open$4.20M$-0.08–
Q1 FY2026
Ended Jul 31, 2025
Sep 15, 2025Before market open$7.60M––
Q3 FY2025
Ended Jan 31, 2025
Mar 12, 2025Before market open–––
Q2 FY2025
Ended Oct 31, 2024
Dec 10, 2024Before market open$6.10M$-0.09–
Q1 FY2025
Ended Jul 31, 2024
Sep 16, 2024Before market open$5.30M$-0.15–
Q4 FY2024
Ended Apr 30, 2024
Jul 24, 2024After market close–––
Q3 FY2024
Ended Jan 31, 2024
Mar 14, 2024Before market open$6.20M$-0.11–
Q2 FY2024
Ended Oct 31, 2023
Nov 27, 2023Before market open–––
Q1 FY2024
Ended Jul 31, 2023
Sep 14, 2023Before market open–––
Q4 FY2023
Ended Apr 30, 2023
Jul 7, 2023Before market open–––
Q3 FY2023
Ended Jan 31, 2023
Mar 16, 2023Before market open–––
Q2 FY2023
Ended Oct 31, 2022
Dec 15, 2022Before market open–––

Press releases

Announcements MindWalk filed with the SEC